Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
about
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation.Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patientsEfficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation.Setting priorities in the health care sector - the case of oral anticoagulants in nonvalvular atrial fibrillation in DenmarkPharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach.Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation.
P2860
Q37672517-EA7E242B-49E6-4003-BE3D-7F7033DF6303Q39129273-BF6243CB-CED4-46D6-A63B-B7F8DC563844Q39452481-2365365B-5478-4B4A-99F9-019AD36064E2Q41524034-AD96B40A-E4E1-4EC5-A184-D678CD7B7A0CQ42244714-A2FF618E-679C-4A55-B82F-B403441A274CQ42368581-6F1AF113-4A03-4F12-BE4A-D8DA871F76C2Q42688289-67B9AF48-FF8C-48D8-B569-E732208604B7Q45974877-0A77C89E-8FF2-41F3-BF5E-C88061B19FE0Q47114806-76697897-F416-4E58-8697-594E6C150DE3Q48024461-7EAEC2B4-1542-4E24-AFCD-E68C2D034A3FQ48158928-D402F22D-1D6F-4651-AFAB-92BC8312EB28Q54249254-2FC39A57-7528-45C8-89FA-86FFCC2C0E5A
P2860
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@en
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@nl
type
label
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@en
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@nl
prefLabel
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@en
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@nl
P2093
P2860
P50
P921
P356
P1476
Ischaemic and haemorrhagic str ...... on: a nationwide cohort study.
@en
P2093
Anders Nissen Bonde
Brice Ozenne
Emil Loldrup Fosbøl
Laila Staerk
Morten Lamberts
Thomas Alexander Gerds
P2860
P304
P356
10.1093/EURHEARTJ/EHW496
P577
2016-10-14T00:00:00Z